318 related articles for article (PubMed ID: 27671543)
1. No impact of disease and its treatment on bone mineral density in survivors of childhood acute lymphoblastic leukemia.
Jain S; Jain S; Kapoor G; Virmani A; Bajpai R
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27671543
[TBL] [Abstract][Full Text] [Related]
2. Bone mineral density, body composition, and height in long-term survivors of acute lymphoblastic leukemia in childhood.
van der Sluis IM; van den Heuvel-Eibrink MM; Hählen K; Krenning EP; de Muinck Keizer-Schrama SM
Med Pediatr Oncol; 2000 Oct; 35(4):415-20. PubMed ID: 11025472
[TBL] [Abstract][Full Text] [Related]
3. Male sex and low physical activity are associated with reduced spine bone mineral density in survivors of childhood acute lymphoblastic leukemia.
Tillmann V; Darlington AS; Eiser C; Bishop NJ; Davies HA
J Bone Miner Res; 2002 Jun; 17(6):1073-80. PubMed ID: 12054163
[TBL] [Abstract][Full Text] [Related]
4. Severity of reduced bone mineral density and risk of fractures in long-term survivors of childhood leukemia and lymphoma undergoing guideline-recommended surveillance for bone health.
Bloomhardt HM; Sint K; Ross WL; Rotatori J; Ness K; Robinson C; Carpenter TO; Chow EJ; Kadan-Lottick NS
Cancer; 2020 Jan; 126(1):202-210. PubMed ID: 31536650
[TBL] [Abstract][Full Text] [Related]
5. Skeletal morbidity in childhood acute lymphoblastic leukemia.
Mandel K; Atkinson S; Barr RD; Pencharz P
J Clin Oncol; 2004 Apr; 22(7):1215-21. PubMed ID: 15051768
[TBL] [Abstract][Full Text] [Related]
6. Relationships of Bone Mineral Density to Whole Body Mass, Fat Mass and Fat-free Mass in Long-term Survivors of Acute Lymphoblastic Leukemia in Childhood.
Athale UH; Marriott CJC; Cranston A; McDonald P; Webber CE; Farncombe TH; Barr RD
J Pediatr Hematol Oncol; 2021 Jan; 43(1):12-17. PubMed ID: 32675554
[TBL] [Abstract][Full Text] [Related]
7. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M
Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
[TBL] [Abstract][Full Text] [Related]
8. Genetic susceptibility and late bone outcomes in childhood acute lymphoblastic leukemia survivors.
Geneviève N; Mojgan Y; Nahid Y; Vincenzo F; Simon G; Daniel S; Maja K; Nathalie A; Despoina M
J Bone Miner Res; 2024 Mar; 39(2):130-138. PubMed ID: 38477791
[TBL] [Abstract][Full Text] [Related]
9. Bone mass after treatment for acute lymphoblastic leukemia in childhood.
Nysom K; Holm K; Michaelsen KF; Hertz H; Müller J; Mølgaard C
J Clin Oncol; 1998 Dec; 16(12):3752-60. PubMed ID: 9850018
[TBL] [Abstract][Full Text] [Related]
10. Bone mineral density in survivors of childhood acute lymphoblastic leukemia.
Athanassiadou F; Tragiannidis A; Rousso I; Katsos G; Sidi V; Papageorgiou T; Papastergiou C; Tsituridis I; Koliouskas D
Turk J Pediatr; 2006; 48(2):101-4. PubMed ID: 16848106
[TBL] [Abstract][Full Text] [Related]
11. Calcium and cholecalciferol supplementation provides no added benefit to nutritional counseling to improve bone mineral density in survivors of childhood acute lymphoblastic leukemia (ALL).
Kaste SC; Qi A; Smith K; Surprise H; Lovorn E; Boyett J; Ferry RJ; Relling MV; Shurtleff SA; Pui CH; Carbone L; Hudson MM; Ness KK
Pediatr Blood Cancer; 2014 May; 61(5):885-93. PubMed ID: 24395288
[TBL] [Abstract][Full Text] [Related]
12. Assessment of bone mineral density and risk factors in children completing treatment for acute lymphoblastic leukemia.
Gunes AM; Can E; Saglam H; Ilçöl YO; Baytan B
J Pediatr Hematol Oncol; 2010 Apr; 32(3):e102-7. PubMed ID: 20216235
[TBL] [Abstract][Full Text] [Related]
13. Bone mineral density and serum bone turnover markers in survivors of childhood acute lymphoblastic leukemia: comparison of megadose methylprednisolone and conventional-dose prednisolone treatments.
Alikasifoglu A; Yetgin S; Cetin M; Tuncer M; Gumruk F; Gurgey A; Yordam N
Am J Hematol; 2005 Oct; 80(2):113-8. PubMed ID: 16184587
[TBL] [Abstract][Full Text] [Related]
14. Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia: a 1-year prospective study.
Marinovic D; Dorgeret S; Lescoeur B; Alberti C; Noel M; Czernichow P; Sebag G; Vilmer E; Léger J
Pediatrics; 2005 Jul; 116(1):e102-8. PubMed ID: 15995009
[TBL] [Abstract][Full Text] [Related]
15. Little evidence of low bone mass in acute lymphoblastic leukemia survivors.
Muszynska-Roslan K; Panasiuk A; Latoch E; Krawczuk-Rybak M; Konstantynowicz J
J Clin Densitom; 2012; 15(1):108-15. PubMed ID: 21880524
[TBL] [Abstract][Full Text] [Related]
16. Long-term skeletal consequences of childhood acute lymphoblastic leukemia in adult males: a cohort study.
Mäkitie O; Heikkinen R; Toiviainen-Salo S; Henriksson M; Puukko-Viertomies LR; Jahnukainen K
Eur J Endocrinol; 2013 Feb; 168(2):281-8. PubMed ID: 23197573
[TBL] [Abstract][Full Text] [Related]
17. Bone mineral density and markers of bone turnover in young adult survivors of childhood lymphoblastic leukaemia.
Hoorweg-Nijman JJ; Kardos G; Roos JC; van Dijk HJ; Netelenbos C; Popp-Snijders C; de Ridder CM; Delemarre-van de Waal HA
Clin Endocrinol (Oxf); 1999 Feb; 50(2):237-44. PubMed ID: 10396368
[TBL] [Abstract][Full Text] [Related]
18. No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia.
van Beek RD; de Muinck Keizer-Schrama SM; Hakvoort-Cammel FG; van der Sluis IM; Krenning EP; Pieters R; van den Heuvel-Eibrink MM
Pediatr Blood Cancer; 2006 Jan; 46(1):88-93. PubMed ID: 15926166
[TBL] [Abstract][Full Text] [Related]
19. Adequate calcium intake during long periods improves bone mineral density in healthy children. Data from the Childhood Obesity Project.
Closa-Monasterolo R; Zaragoza-Jordana M; Ferré N; Luque V; Grote V; Koletzko B; Verduci E; Vecchi F; Escribano J;
Clin Nutr; 2018 Jun; 37(3):890-896. PubMed ID: 28351509
[TBL] [Abstract][Full Text] [Related]
20. Total body bone measurements: a cross-sectional study in children with acute lymphoblastic leukemia during and following completion of therapy.
Kelly KM; Thornton JC; Hughes D; Osunkwo I; Weiner M; Wang J; Horlick M
Pediatr Blood Cancer; 2009 Jan; 52(1):33-8. PubMed ID: 18816694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
